AU2491095A - Compositions and methods for inhibiting growth or replication of viruses - Google Patents
Compositions and methods for inhibiting growth or replication of virusesInfo
- Publication number
- AU2491095A AU2491095A AU24910/95A AU2491095A AU2491095A AU 2491095 A AU2491095 A AU 2491095A AU 24910/95 A AU24910/95 A AU 24910/95A AU 2491095 A AU2491095 A AU 2491095A AU 2491095 A AU2491095 A AU 2491095A
- Authority
- AU
- Australia
- Prior art keywords
- replication
- viruses
- compositions
- methods
- inhibiting growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
- C12N15/1133—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against herpetoviridae, e.g. HSV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/312—Phosphonates
- C12N2310/3125—Methylphosphonates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Epidemiology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58618590A | 1990-09-21 | 1990-09-21 | |
US586185 | 1990-09-21 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU87566/91A Division AU8756691A (en) | 1990-09-21 | 1991-09-18 | Compositions and methods for inhibiting growth or replication of viruses |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2491095A true AU2491095A (en) | 1995-11-02 |
Family
ID=24344663
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU87566/91A Abandoned AU8756691A (en) | 1990-09-21 | 1991-09-18 | Compositions and methods for inhibiting growth or replication of viruses |
AU24910/95A Abandoned AU2491095A (en) | 1990-09-21 | 1995-07-07 | Compositions and methods for inhibiting growth or replication of viruses |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU87566/91A Abandoned AU8756691A (en) | 1990-09-21 | 1991-09-18 | Compositions and methods for inhibiting growth or replication of viruses |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0656942A1 (en) |
JP (1) | JPH06501162A (en) |
AU (2) | AU8756691A (en) |
CA (1) | CA2092711A1 (en) |
IE (1) | IE913321A1 (en) |
IL (1) | IL99543A0 (en) |
NZ (1) | NZ239883A (en) |
WO (1) | WO1992005284A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2089476A1 (en) * | 1990-08-15 | 1992-02-16 | Bernard Roizman | Inhibition of herpesviridae infection by antisense oligonucleotides |
EP0649466A1 (en) * | 1992-07-02 | 1995-04-26 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Method of inhibiting viral replication |
CA2105595A1 (en) * | 1992-09-23 | 1994-03-24 | Ramaswamy Narayanan | Antisense polynucleotides |
FR2708270B1 (en) * | 1993-07-28 | 1995-10-20 | Genset Sa | Antisense oligonucleotides directed against Herpes Simplex virus types 1 & 2. |
DE4331670A1 (en) * | 1993-09-17 | 1995-03-23 | Hoechst Ag | Antisense oligonucleotides against HSV-1 and the preparation thereof |
ATE188479T1 (en) | 1994-06-01 | 2000-01-15 | Hybridon Inc | BRANCHED OLIGONUCLEOTIDES AS PATHOGENE INHIBITING AGENTS |
US7176303B2 (en) | 2003-11-06 | 2007-02-13 | Isis Pharmaceuticals, Inc. | Modulation of STAT5 expression |
WO2024113302A1 (en) * | 2022-12-01 | 2024-06-06 | 深圳先进技术研究院 | Grna targeting hsv essential genes, crispr/cas gene editing system, delivery system, and use |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ209840A (en) * | 1983-10-17 | 1988-11-29 | Kaji Akira | A method of inhibiting viral propagation by hybridising dna with the viral rna thus blocking its action |
US4806463A (en) * | 1986-05-23 | 1989-02-21 | Worcester Foundation For Experimental Biology | Inhibition of HTLV-III by exogenous oligonucleotides |
DE68925278T2 (en) * | 1988-02-26 | 1996-09-19 | Worcester Found Ex Biology | INHIBITION OF HTLV-III BY EXOGENE OLIGONUCLEOTIDES |
US5004810A (en) * | 1988-09-30 | 1991-04-02 | Schering Corporation | Antiviral oligomers |
-
1991
- 1991-09-18 WO PCT/US1991/006646 patent/WO1992005284A1/en not_active Application Discontinuation
- 1991-09-18 AU AU87566/91A patent/AU8756691A/en not_active Abandoned
- 1991-09-18 JP JP3517870A patent/JPH06501162A/en active Pending
- 1991-09-18 EP EP91918745A patent/EP0656942A1/en not_active Withdrawn
- 1991-09-18 CA CA002092711A patent/CA2092711A1/en not_active Abandoned
- 1991-09-20 NZ NZ239883A patent/NZ239883A/en unknown
- 1991-09-20 IL IL99543A patent/IL99543A0/en unknown
- 1991-09-20 IE IE332191A patent/IE913321A1/en not_active Application Discontinuation
-
1995
- 1995-07-07 AU AU24910/95A patent/AU2491095A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
IL99543A0 (en) | 1992-08-18 |
CA2092711A1 (en) | 1992-03-22 |
JPH06501162A (en) | 1994-02-10 |
IE913321A1 (en) | 1992-02-25 |
EP0656942A1 (en) | 1995-06-14 |
NZ239883A (en) | 1993-10-26 |
EP0656942A4 (en) | 1998-04-15 |
WO1992005284A1 (en) | 1992-04-02 |
AU8756691A (en) | 1992-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2045192A (en) | Compounds and methods for inhibition of hiv and related viruses | |
AU1460192A (en) | Method and compositions for inducing bone growth | |
AU4032989A (en) | Method and compositions for the treatment and prevention of septic shock | |
AU4387689A (en) | Unpleasant taste masking compositions and methods for preparing same | |
IL117873A0 (en) | Pharmaceutical compositions for inhibiting the growth of viruses and cancers | |
AU6110990A (en) | Use of viruses against undesirable micro-organisms | |
ZA962879B (en) | A pharmaceutical composition for inhibiting the growth of viruses and cancers | |
IL117876A0 (en) | Pharmaceutical compositions for inhibiting the growth of viruses and cancers | |
AU6774294A (en) | Methods of preventing viral replication | |
AU5872294A (en) | Compositions and methods for inhibiting deoxyhypusine synthase and the growth of cells | |
AU2065992A (en) | Herbicidal compositions and methods of preparing and using the same | |
AU1448092A (en) | Splitter and method of forming it | |
AU8044491A (en) | Antitumor compositions and methods of treatment | |
AU3586395A (en) | Methods and compositions for inhibiting production of replication competent virus | |
ZA962878B (en) | A pharmaceutical composition for inhibiting the growth of viruses and cancers | |
HUP9900901A3 (en) | A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers | |
ZA962880B (en) | A pharmaceutical composition for inhibiting the growth of viruses and cancers | |
AU6125890A (en) | Method and composition for destroying or inhibiting growth of microorganisms | |
AU8155394A (en) | Methods of inhibiting Turner's syndrome | |
AU2491095A (en) | Compositions and methods for inhibiting growth or replication of viruses | |
AU636741B2 (en) | Treatment of plants for frost protection | |
AU5183490A (en) | Composition for the inhibition of tumors and for the non-cytotoxic inhibition of replication of viruses | |
AU8920191A (en) | Methods and compositions for minimizing inhibition of nucleic acid amplification | |
AU6962894A (en) | Compositions and methods for inhibiting replication of human immunodeficiency virus-1 | |
AU7770991A (en) | Method and composition for the treatment of cancer |